Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Large Portfolio, Competitive Prices, High Quality to Be Key to Success in Generics Business: Mr Bourla of Pfizer
August 27, 2012
-
BUSINESS Kyowa Kirin, Otsuka Still Working Out Specifics for Cooperation in Field of Oncology
August 27, 2012
-
BUSINESS Pfizer, Mylan Ink Strategic Collaboration in Japan Generics Biz; Aim for No. 3 in Market
August 24, 2012
-
REGULATORY MHLW to Recommend Use of ReQuip CR Tablets
August 23, 2012
-
REGULATORY PMDA’s Regulatory Consultation Service Off to Good Start, but More Effort Needed to Promote Face-to-Face Advisory Meetings: Dr Isobe
August 22, 2012
-
BUSINESS Mediscience Stepping Up Athlete Recruitments as CMRs
August 21, 2012
-
REGULATORY Healthcare to Receive Priority in FY2013 Draft Budget Request Guidelines
August 21, 2012
-
BUSINESS DSP to Set Up Cancer Institute Led by CEO of Its US Subsidiary BBI
August 21, 2012
-
REGULATORY PAFSC’s 1st Committee to Review 7 Products Including Bayer Yakuhin’s AMD Drug on Aug. 31
August 20, 2012
-
BUSINESS “Sense of Achievement” Motivates MRs; Brach Managers to Be Blamed for Miscommunications: Survey of Managers
August 20, 2012
-
REGULATORY US Regulation Could Delay Introduction of PBRER as ICH Standard
August 17, 2012
-
REGULATORY MHLW Approves Allegra Generics of 3 Companies for Listing in December
August 16, 2012
-
BUSINESS Differences in Concurrent-Use Indications for DPP-4 Inhibitors to Be Eliminated through Special Clinical Trials
August 15, 2012
-
REGULATORY Neo-Morgan Laboratory Developing a Variety of Organisms Using “Disparity Mutagenesis Technology”
August 14, 2012
-
BUSINESS Business Strategies of Generics Manufacturers Become Evident Ahead of Upcoming Round of Patent Expiries
August 13, 2012
-
REGULATORY MHLW to Include Generic Drug Share Targets in Next 5-Year Medical Spending Optimization Plans in Response to Requests by Insurers
August 10, 2012
-
ORGANIZATION PI Forum to Make Proposals to Promote R&D, Make Pharmaceuticals Japan’s Key Industry: Chairman Toyoda
August 9, 2012
-
BUSINESS Daiichi Sankyo to Strengthen Cardiovascular Field by Comarketing Diabetes Treatments, Focusing on SGLT-2 Inhibitor
August 8, 2012
-
REGULATORY MOF Wants Generic Drug Share to Reach European, US Levels: Budget Examiner Shinkawa
August 8, 2012
-
BUSINESS 6 Listed Wholesalers Post Low Price Settlement Rates as of End-June, Showing Declines Compared to 2 Years Earlier
August 7, 2012
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…